| Here's Why Tenet Healthcare (THC) is a Strong Momentum Stock |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-05-16 14:56:28 |
Czytaj oryginał (ang.) |
| Here's Why Tenet Healthcare (THC) is a Strong Value Stock |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2025-05-12 14:46:02 |
Czytaj oryginał (ang.) |
| Top Analyst-Rated Healthcare Stocks to Watch Now |
It has been a turbulent start to the year for the healthcare industry, as concerns about major cuts to Medicare and Medicaid coincide with the impact of tariffs on supplies and many other variables. Nonetheless, healthcare stocks have fared well compared to the energy and information technology sectors. |
marketbeat.com |
2025-05-11 11:01:31 |
Czytaj oryginał (ang.) |
| Tenet to Participate in BofA Securities 2025 Health Care Conference |
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, beginning at 1:40 p.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare service. |
businesswire.com |
2025-05-09 20:00:00 |
Czytaj oryginał (ang.) |
| Is Trending Stock Tenet Healthcare Corporation (THC) a Buy Now? |
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. |
zacks.com |
2025-05-07 14:06:09 |
Czytaj oryginał (ang.) |
| Here's Why Tenet Healthcare (THC) is a Strong Growth Stock |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2025-05-06 14:50:41 |
Czytaj oryginał (ang.) |
| Despite Fast-paced Momentum, Tenet (THC) Is Still a Bargain Stock |
Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices. |
zacks.com |
2025-05-02 13:50:41 |
Czytaj oryginał (ang.) |
| Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks |
Top-ranked stocks Fox (FOXA), Universal Technical Institute (UTI), Pfizer (PFE), Tenet Healthcare (THC) and Newmont (NEM) are likely to beat on the bottom line in their upcoming releases. |
zacks.com |
2025-05-01 13:40:46 |
Czytaj oryginał (ang.) |
| Tenet Beats Q1 Earnings on Strong Ambulatory Unit, Ups '25 EPS View |
THC's first-quarter results benefit on the back of higher net revenue per case and the expansion of service lines within the Ambulatory Care unit. It currently expects 2025 adjusted EPS within $11.99-$13.12. |
zacks.com |
2025-04-30 18:00:30 |
Czytaj oryginał (ang.) |
| Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2025-04-30 14:55:47 |
Czytaj oryginał (ang.) |
| Tenet Healthcare Corporation (THC) Q1 2025 Earnings Call Transcript |
Tenet Healthcare Corporation (NYSE:THC ) Q1 2025 Earnings Conference Call April 29, 2025 10:00 AM ET Company Participants William McDowell - Vice President-Investor Relations Saum Sutaria - Chairman and Chief Executive Officer Sun Park - Executive Vice President and Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Craig Hettenbach - Morgan Stanley Investment Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Megan Holt - Jefferies Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Ben Hendrix - RBC Capital Markets Whit Mayo - Leerink Partners Ann Hynes - Mizuho Securities Benjamin Rossi - JPMorgan Chase A.J. Rice - UBS Andrew Mok - Barclays Josh Raskin - Nephron Research Operator Good morning and welcome to Tenet Healthcare's First Quarter 2025 Earnings Conference Call. |
seekingalpha.com |
2025-04-29 19:48:19 |
Czytaj oryginał (ang.) |
| Tenet (THC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates |
While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2025-04-29 15:30:44 |
Czytaj oryginał (ang.) |
| Tenet Healthcare (THC) Surpasses Q1 Earnings and Revenue Estimates |
Tenet Healthcare (THC) came out with quarterly earnings of $4.36 per share, beating the Zacks Consensus Estimate of $3.11 per share. This compares to earnings of $3.22 per share a year ago. |
zacks.com |
2025-04-29 12:55:20 |
Czytaj oryginał (ang.) |
| Tenet Reports Strong First Quarter 2025 Results |
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2025. "We had an excellent start to the year driven by strong same-store revenue growth and operational discipline, resulting in earnings and cash flows well ahead of our expectations," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We continue to expand access to high-quality specialty care as we effectively execute on our mission to de. |
businesswire.com |
2025-04-29 10:45:00 |
Czytaj oryginał (ang.) |
| Doctor's Orders: 4 Hospital Stocks to Benefit From Industry Trends |
The Zacks Medical-Hospital industry is likely to gain from growing demand, improving operating stability and finances. Companies like HCA, THC, UHS and CYH are poised to benefit from these trends. |
zacks.com |
2025-04-28 16:00:45 |
Czytaj oryginał (ang.) |
| Stay Ahead of the Game With Tenet (THC) Q1 Earnings: Wall Street's Insights on Key Metrics |
Besides Wall Street's top -and-bottom-line estimates for Tenet (THC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025. |
zacks.com |
2025-04-28 14:21:36 |
Czytaj oryginał (ang.) |
| Tenet Healthcare (THC) Stock Drops Despite Market Gains: Important Facts to Note |
In the most recent trading session, Tenet Healthcare (THC) closed at $122.10, indicating a -1.72% shift from the previous trading day. |
zacks.com |
2025-04-25 23:05:44 |
Czytaj oryginał (ang.) |
| All You Need to Know About Tenet (THC) Rating Upgrade to Buy |
Tenet (THC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). |
zacks.com |
2025-04-25 17:05:37 |
Czytaj oryginał (ang.) |
| Is Tenet Healthcare (THC) Stock Undervalued Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2025-04-25 14:46:05 |
Czytaj oryginał (ang.) |
| Wall Street Analysts Think Tenet (THC) Is a Good Investment: Is It? |
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? |
zacks.com |
2025-04-25 14:36:10 |
Czytaj oryginał (ang.) |
| These 2 REITs Make Great Buys For Income Investors |
REITs have surged in value. But opportunities still remain for income-oriented investors. I present two REITs to buy today. |
seekingalpha.com |
2025-02-27 10:25:00 |
Czytaj oryginał (ang.) |
| 5 Top-Ranked Stocks Poised for an Earnings Beat |
Top-ranked stocks Tenet Healthcare (THC), Fortinet (FTNT), Lyft (LYFT), Garmin (GRMN) and Doximity (DOCS) are likely to beat on the bottom line in their upcoming releases. |
zacks.com |
2025-02-25 10:50:46 |
Czytaj oryginał (ang.) |
| Should Value Investors Buy Tenet Healthcare (THC) Stock? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2025-02-24 12:45:33 |
Czytaj oryginał (ang.) |
| 4 Healthcare Stocks to Buy as the Sector Stages a Comeback |
Buy healthcare stocks like WGS, THC, RIGL and ENSG for steady returns as the focus shifts to the incoming Trump administration's healthcare policies. |
zacks.com |
2025-02-24 11:15:30 |
Czytaj oryginał (ang.) |
| Tenet Q4 Earnings Beat Estimates on Favorable Payer Mix |
THC expects net operating revenues between $20.6 billion and $21 billion in 2025. |
zacks.com |
2025-02-13 14:01:18 |
Czytaj oryginał (ang.) |
| Tenet Healthcare Corporation (THC) Q4 2024 Earnings Call Transcript |
Tenet Healthcare Corporation (NYSE:THC ) Q4 2024 Earnings Conference Call February 12, 2025 10:00 AM ET Company Participants Will McDowell - Vice President of Investor Relations Saumya Sutaria - Chairman and Chief Executive Officer Sun Park - Executive Vice President and Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Andrew Mok - Barclays Justin Lake - Wolfe Research Benjamin Rossi - JPMorgan Chase Joanna Gajuk - Bank of America A.J Rice - UBS Stephen Baxter - Wells Fargo Michael Ha - Baird Ann Hynes - Mizuho Whit Mayo - Leerink Partners John Ransom - Raymond James Josh Raskin - Nephron Research Matthew Gillmor - KeyBanc Mike Murray - RBC Capital Markets Operator Good morning. Welcome to Tenet Healthcare's Fourth Quarter 2024 Earnings Conference Call. |
seekingalpha.com |
2025-02-12 17:26:01 |
Czytaj oryginał (ang.) |
| Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics |
The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
zacks.com |
2025-02-12 12:36:42 |
Czytaj oryginał (ang.) |
| Tenet Healthcare (THC) Surpasses Q4 Earnings Estimates |
Tenet Healthcare (THC) came out with quarterly earnings of $3.44 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.68 per share a year ago. |
zacks.com |
2025-02-12 10:56:07 |
Czytaj oryginał (ang.) |
| Tenet Reports Strong Fourth Quarter and FY 2024 Results; Provides 2025 Financial Outlook |
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2024. "2024 was an outstanding year for Tenet characterized by robust revenue growth, efficient operations, high levels of patient satisfaction and clinical quality, and a portfolio transformation that drove substantial balance sheet deleveraging," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "Our focused strategy, disciplined operat. |
businesswire.com |
2025-02-12 08:45:00 |
Czytaj oryginał (ang.) |
| Can Tenet Healthcare Navigate Through Lower Revenues in Q4? |
THC's fourth-quarter results are likely to reflect growing patient admissions, utilization and patient days. |
zacks.com |
2025-02-11 14:31:09 |
Czytaj oryginał (ang.) |
| Wall Street Analysts See Tenet (THC) as a Buy: Should You Invest? |
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. |
zacks.com |
2025-02-07 12:31:35 |
Czytaj oryginał (ang.) |
| Countdown to Tenet (THC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS |
Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. |
zacks.com |
2025-02-07 12:21:34 |
Czytaj oryginał (ang.) |
| Tenet Healthcare (THC) Stock Drops Despite Market Gains: Important Facts to Note |
Tenet Healthcare (THC) closed the most recent trading day at $143.71, moving -0.64% from the previous trading session. |
zacks.com |
2025-02-04 21:05:44 |
Czytaj oryginał (ang.) |
| Thriving in Healthcare: 5 Hospital Stocks to Keep on Your Radar |
The Zacks Medical-Hospital industry is likely to benefit from improving financial, operating and staffing stability. Companies like HCA, THC, UHS, ACHC and CYH are well-positioned to gain from these trends. |
zacks.com |
2025-02-03 12:30:49 |
Czytaj oryginał (ang.) |
| Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know |
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. |
zacks.com |
2025-01-30 12:00:37 |
Czytaj oryginał (ang.) |
| Tenet Healthcare (THC) Advances But Underperforms Market: Key Facts |
The latest trading day saw Tenet Healthcare (THC) settling at $139.67, representing a +0.56% change from its previous close. |
zacks.com |
2025-01-28 21:06:22 |
Czytaj oryginał (ang.) |
| Here's Why Tenet Healthcare (THC) is a Strong Growth Stock |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2025-01-27 12:45:38 |
Czytaj oryginał (ang.) |
| Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-01-23 12:41:08 |
Czytaj oryginał (ang.) |
| Tenet Healthcare (THC) Stock Dips While Market Gains: Key Facts |
Tenet Healthcare (THC) concluded the recent trading session at $134.42, signifying a -0.01% move from its prior day's close. |
zacks.com |
2025-01-22 21:21:23 |
Czytaj oryginał (ang.) |
| Should You Invest in Tenet (THC) Based on Bullish Wall Street Views? |
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? |
zacks.com |
2025-01-22 12:31:46 |
Czytaj oryginał (ang.) |
| Should You Buy Tenet Healthcare Stock Now at Cheaper Valuation? |
As occupancy levels rise and resource utilization grows, THC's operating costs are expected to continue increasing. |
zacks.com |
2025-01-02 18:06:20 |
Czytaj oryginał (ang.) |
| Are Investors Undervaluing Tenet Healthcare (THC) Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-12-31 13:01:41 |
Czytaj oryginał (ang.) |
| Tenet Healthcare Stock: An Improved Option Here (Rating Upgrade) |
Tenet Healthcare Corporation has significantly improved its financial health by selling hospitals, reducing leverage, while achieving strong operating performance. The company has focused on quality over growth, with substantial revenue from Ambulatory Care, which boasts higher margins than Hospital Operations. After recent share pullbacks due to election outcomes and earlier momentum, Tenet's earnings power and reduced debt make it a compelling buy. |
seekingalpha.com |
2024-12-30 13:46:27 |
Czytaj oryginał (ang.) |
| Wall Street Top Picks: 3 Healthcare Stocks Analysts Are Bullish About |
The long-term outlook for the healthcare sector remains favorable, with profits expected to rise; analysts are bullish on THC, EHC and ENSG stocks. |
zacks.com |
2024-12-26 18:00:31 |
Czytaj oryginał (ang.) |
| Tenet (THC) Upgraded to Buy: Here's Why |
Tenet (THC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
zacks.com |
2024-12-26 15:01:16 |
Czytaj oryginał (ang.) |
| Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know |
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. |
zacks.com |
2024-12-26 12:01:19 |
Czytaj oryginał (ang.) |
| Here's Why Tenet Healthcare (THC) is a Strong Growth Stock |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2024-12-24 12:45:26 |
Czytaj oryginał (ang.) |
| Tenet Healthcare (THC) Advances But Underperforms Market: Key Facts |
In the most recent trading session, Tenet Healthcare (THC) closed at $129.64, indicating a +0.14% shift from the previous trading day. |
zacks.com |
2024-12-23 21:05:37 |
Czytaj oryginał (ang.) |
| Here's Why Tenet Healthcare (THC) is a Strong Value Stock |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2024-12-20 12:46:47 |
Czytaj oryginał (ang.) |
| Tenet Healthcare: Walk-In Surgical Care Facilities Are A Key Revenue Driver |
Tenet Healthcare is well-positioned for long-term growth due to rising healthcare demand and strategic focus on cost-efficient outpatient services. Financials show strong revenue and net income growth, driven by asset sales, higher operating income, and expense management. Ambulatory Surgery Centers are set for continued revenue growth and are likely to be a key driver of Tenet's continues success. |
seekingalpha.com |
2024-12-17 05:26:27 |
Czytaj oryginał (ang.) |
| Buy These 4 Stocks With Attractive Interest Coverage Ratio |
STRL, LDOS, THC & AMZN's impressive interest coverage ratios highlight that these companies can withstand financial hardships. |
zacks.com |
2024-12-16 14:06:10 |
Czytaj oryginał (ang.) |
| Tenet Healthcare downgraded to Neutral from Buy at Goldman Sachs |
Goldman Sachs analyst Jamie Perse downgraded Tenet Healthcare to Neutral from Buy with a price target of $140, down from $196. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. For Tenet, the analyst sees policy risk "taking center stage" and likely leaving shares range bound until policy outcomes are better defined, reflected in out year estimates, and in the stock's valuation. |
https://thefly.com |
2024-12-16 07:18:38 |
Czytaj oryginał (ang.) |
| LifeStance upgraded to Buy from Neutral at Goldman Sachs |
Goldman Sachs upgraded LifeStance to Buy from Neutral with a $10 price target. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. The analyst believes LifeStance's continued operational execution will continue in 2025, and on an organic basis, Goldman's analysis suggests its EBITDA can grow 27% through 2027. |
https://thefly.com |
2024-12-16 07:17:36 |
Czytaj oryginał (ang.) |
| Universal Health downgraded to Neutral from Buy at Goldman Sachs |
Goldman Sachs downgraded Universal Health to Neutral from Buy with a price target of $198, down from $228. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. For Universal Health, the analyst sees policy risk "taking center stage" and likely leaving shares range bound until policy outcomes are better defined, reflected in out year estimates, and in the stock's valuation. |
https://thefly.com |
2024-12-16 07:16:25 |
Czytaj oryginał (ang.) |
| Is Tenet Healthcare (THC) Stock Undervalued Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-12-13 12:41:29 |
Czytaj oryginał (ang.) |
| After Plunging -16.78% in 4 Weeks, Here's Why the Trend Might Reverse for Tenet (THC) |
The heavy selling pressure might have exhausted for Tenet (THC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. |
zacks.com |
2024-12-13 12:35:22 |
Czytaj oryginał (ang.) |
| Wall Street Analysts Look Bullish on Tenet (THC): Should You Buy? |
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? |
zacks.com |
2024-12-12 12:31:25 |
Czytaj oryginał (ang.) |
| Tenet (THC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now |
Tenet (THC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. |
zacks.com |
2024-12-05 12:55:18 |
Czytaj oryginał (ang.) |
| Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2024-12-05 12:51:03 |
Czytaj oryginał (ang.) |
| Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock |
Recently, Zacks.com users have been paying close attention to Tenet (THC). This makes it worthwhile to examine what the stock has in store. |
zacks.com |
2024-12-05 12:00:28 |
Czytaj oryginał (ang.) |